Michael Reutlinger - Concepedia

Author

Michael Reutlinger

ETH Zurich ORCID

Also Known As

M Reutlinger, M. Reutlinger, Michael Reutlinger, Reutlinger, Michael, Reutlinger, Michael R.

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

ETH Zurich Roche (Switzerland)Board of the Swiss Federal Institutes of Technology PTC Therapeutics (United States)Goethe University Frankfurt

About

Michael Reutlinger is an author at ETH Zurich specializing in medicine, drug discovery, and molecular docking.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	519
2	Engineering	6	6	255
3	Natural Sciences	5	5	314
4	Biochemistry	5	5	413
5	Biomedical Engineering	1	1	41

Michael Reutlinger

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
Discovery of Risdiplam, a Selective Survival of Motor Neuron-2 ( <i>SMN2</i> ) Gene Splicing Modifier for the Treatment of Spinal Muscular Atrophy (SMA) Hasane Ratni, Martin Ebeling, John D. Baird, Journal of Medicinal Chemistry	2018	492
Chemically Advanced Template Search (CATS) for Scaffold‐Hopping and Prospective Target Prediction for ‘Orphan’ Molecules Michael Reutlinger, Christian P. Koch, Daniel Reker, Molecular Informatics Drug TargetScaffold-hopping PotentialMolecular BiologyAdvanced Template SearchChemical Biology	2013	162
Revealing the macromolecular targets of complex natural products Daniel Reker, Anna Maria Perna, Tiago Rodrigues, Nature Chemistry BiochemistryNatural Product BiosynthesisNatural Product SynthesisSmall Molecule LibraryComplex Natural Products	2014	131
Rationalizing Tight Ligand Binding through Cooperative Interaction Networks Bernd Kuhn, Julian E. Fuchs, Michael Reutlinger, Journal of Chemical Information and Modeling Molecular RecognitionEngineeringInteractomicsSmall ModificationsMedicine	2011	100
Multi‐Objective Molecular De Novo Design by Adaptive Fragment Prioritization Michael Reutlinger, Tiago Rodrigues, Petra Schneider, Angewandte Chemie International Edition	2014	92
Combining On‐Chip Synthesis of a Focused Combinatorial Library with Computational Target Prediction Reveals Imidazopyridine GPCR Ligands Michael Reutlinger, Tiago Rodrigues, Petra Schneider, Angewandte Chemie International Edition	2013	69
Machine Learning Estimates of Natural Product Conformational Energies Matthias Rupp, Matthias R. Bauer, Rainer Wilcken, PLoS Computational Biology EngineeringMachine LearningComputational ChemistryEnergy MinimizationMolecular Dynamics	2014	47
Multidimensional De Novo Design Reveals 5‐HT<sub>2B</sub> Receptor‐Selective Ligands Tiago Rodrigues, N. Hauser, Daniel Reker, Angewandte Chemie International Edition Drug TargetEngineeringMolecular BiologyBiomedical EngineeringSynthetic Tractability	2014	41
Reaction-Driven <i>De Novo</i> Design, Synthesis and Testing of Potential Type II Kinase Inhibitors Gisbert Schneider, Tim Geppert, Markus Hartenfeller, Future Medicinal Chemistry	2011	40
Immunosuppressive Small Molecule Discovered by Structure‐Based Virtual Screening for Inhibitors of Protein–Protein Interactions Tim Geppert, Stefanie Bauer, Jan A. Hiss, Angewandte Chemie International Edition Protein–protein InteractionsDrug TargetMolecular BiologyAntiviral DrugLead Compound	2011	40

Page 1